Vancouver, Canada – April 22, 2026 – Augurex Life Sciences Corp., a leader in the development of autoimmune-based diagnostics, today announced that the company will attend the Northwest Rheumatism Society (NWRS) Annual Meeting, taking place April 30 – May 2, 2026 in Vancouver, Canada.
The Northwest Rheumatism Society Annual Meeting brings together rheumatology clinicians, researchers, and healthcare professionals from across the Pacific Northwest to discuss advances in inflammatory arthritis, clinical care, and emerging developments in the field.
Augurex looks forward to engaging with the rheumatology community during the meeting and participating in discussions around improving patient care through advances in diagnostics and clinical decision support.
As a company focused on biomarker-driven diagnostics in autoimmune inflammatory arthritis, such as JOINTstat® (14-3-3eta) for rheumatoid arthritis and SPINEstat® (Anti-14-3-3eta Multiplex) for axial spondyloarthritis, Augurex continues to support initiatives that help advance earlier identification and more informed management of autoimmune and inflammatory diseases.
If you are attending the meeting and would like to connect with the Augurex team during the conference, please reach out directly to coordinate a time.
For more information about the meeting, visit:
About Augurex
Augurex is a commercial-stage diagnostics company dedicated to the early identification and diagnosis of autoimmune disorders, allowing treatment options to be optimized and personalized for patients around the world. Augurex’s 14-3-3eta blood test, available as JOINTstat® in Canada and in Great Britain, is an important tool in the diagnosis and management of rheumatoid arthritis. Analyte-specific reagents to detect 14-3-3eta are available for purchase and use by U.S. clinical laboratories as a component of diagnostic tests developed by such laboratories. The Anti-14-3-3eta Multiplex test, approved as SPINEstat® in Canada and Great Britain, expands Augurex’s portfolio of autoimmune diagnostic solutions into axial spondyloarthritis, an autoimmune disease often misdiagnosed as low back pain, which, if untreated, can lead to impaired spinal mobility and fusion of the vertebrae. Learn more about Augurex at www.augurex.com and follow us on Facebook, LinkedIn, and X.